 |
Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era? Danny Robson, Sunil Verma (p. 950) |
|
Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era? Kathleen I. Pritchard (p. 959) |
|
NCCTG Study N9741: Leveraging Learning from an NCI Cooperative Group Phase III Trial Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Erin Green, Hanna K. Sanoff, Howard McLeod, Jan Buckner (p. 970) |
|
Should Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy? Scott M. Schuetze, Shreyaskumar Patel (p. 1003) |
|
Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven Jean-Yves Blay, Axel Le Cesne (p. 1013) |
|
Contemporary Imaging in Sarcoma Jonathan Landa, Lawrence H. Schwartz (p. 1021) |
|
The Assessment and Management of Delirium in Cancer Patients Shirley H. Bush, Eduardo Bruera (p. 1039) |
|
The Oncologist Online is grateful for the support of:
The Oncologist is the
official journal of
|
